Trials / Unknown
UnknownNCT04570072
Effect of Probiotic on Comorbidity of Depression and Constipation
Effect of Probiotic on Chinese Patients With Depression and Constipated Comorbidity
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- China Agricultural University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Depressive disorder, also known as depression, is a type of mood disorder characterized by persistent low mood. The incidence of depression worldwide is about 6%. The high comorbidity rate between depression and constipation indicated the role of the gut-brain axis in depression. Growing evidence suggested that the gut microbiota plays a key role in the development of depression. Probiotics can effectively improve constipation and regulate gut microbiota, and showed potential in alleviating depression. This study investigated the effect of formula probiotic (containing Lactobacillus paracasei, Bifidobacterium animals, Bifidobacterium longum, Bifidobacterium bifidum, and Lactobacillus plantarum) on the comorbidity of depression and constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | Patients receive the formula probiotic for consecutive 8 weeks ( one sachet per day ). |
| DIETARY_SUPPLEMENT | Placebo | Patients receive the placebo identical to probiotic for consecutive 8 weeks ( one sachet per day ). |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2021-06-30
- Completion
- 2021-12-30
- First posted
- 2020-09-30
- Last updated
- 2020-09-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04570072. Inclusion in this directory is not an endorsement.